Johns Hopkins scientists develop mRNA "booster" as potential new way to treat rare genetic diseases marked by too low levels ...

Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.

Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic ...

Researchers have found a way to use tardigrade proteins to potentially revolutionize cancer treatment and space travel.

called mRNA, to produce a specific protein. COVID-19 vaccines, an example of an mRNA vaccine, work by injecting a COVID-19 protein into the vaccine, which the body’s immune system then recognizes and ...

Boosting cells with a tardigrade protein reduced DNA damage after radiation, offering potential protection for healthy tissue ...

As it did during the COVID-19 pandemic, mRNA technology offers an efficient way forward in developing products for diseases ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

Emerging tools enable more accurate antigen production and presentation using mRNA instead of protein. In recent years, mRNA technology has come into its own, most prominently in the field of vaccine ...